ACVR2A and heart failure: ACTRII activation induces a pathological phenotype in cardiomyocytes, triggering heart failure transcriptional profiles, causing cardiac atrophy, reducing the levels of the SERCA2a protein, and possibly decreasing the myocardial energy consumption.